81R1716 TJS-D
 
  By: Zerwas H.B. No. 4572
 
 
 
A BILL TO BE ENTITLED
 
AN ACT
  relating to insurance coverage for certain devices that facilitate
  insulin therapy and enhance glucose control in the treatment of
  diabetes.
         BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
         SECTION 1.  Sections 1358.051(1) and (2), Insurance Code,
  are amended to read as follows:
               (1)  "Diabetes equipment" means:
                     (A)  blood glucose monitors, including
  noninvasive glucose monitors and glucose monitors designed to be
  used by blind individuals;
                     (B)  insulin pumps and associated appurtenances;
                     (C)  insulin infusion devices and devices that
  facilitate insulin therapy and enhance glucose control; and
                     (D)  podiatric appliances for the prevention of
  complications associated with diabetes.
               (2)  "Diabetes supplies" means:
                     (A)  test strips for blood glucose monitors;
                     (B)  visual reading and urine test strips;
                     (C)  lancets and lancet devices;
                     (D)  insulin and insulin analogs;
                     (E)  injection aids and devices that facilitate
  insulin therapy and enhance glucose control;
                     (F)  syringes;
                     (G)  prescriptive and nonprescriptive oral agents
  for controlling blood sugar levels; and
                     (H)  glucagon emergency kits.
         SECTION 2.  This Act applies only to an insurance policy that
  is delivered, issued for delivery, or renewed on or after January 1,
  2010. A policy delivered, issued for delivery, or renewed before
  January 1, 2010, is governed by the law as it existed immediately
  before the effective date of this Act, and that law is continued in
  effect for that purpose.
         SECTION 3.  This Act takes effect September 1, 2009.